OVERVIEW

IMrh-Internal Medicine- Rheumatology is organized by American Medical Seminars (AMS), Inc. This course has been approved for a maximum of 5 AMA PRA Category 1 Credits™.

Original Release Date: July 1, 2021
Expiration Date: July 1, 2024

TOPIC 1:Osteoporosis.
Upon completion of this session, the participant should be able to: GL, EBM, COMP
• Detect patients who are at risk for osteoporosis.
• Recognize the need for bone density testing as recommended by the International Society of Clinical Densitometry and the National Osteoporosis Foundation guidelines.
• Differentiate the nonpharmacologic and pharmacologic treatments for osteoporosis as recommended by the National Osteoporosis Foundation guidelines.

TOPIC 2: Scleroderma and Raynaud’s Disease.
Upon completion of this session, the participant should be able to: GL, COMP
• Specify the clinical manifestations of scleroderma.
• Apply the ACR/EULAR classification criteria for systemic sclerosis.
• Utilize treatment available for symptomatic manifestations as per the current EULAR recommendations.
• Apply the diagnostic work-up and treatment of Raynaud’s Phenomenon.

TOPIC 3: Rheumatoid Arthritis.
Upon completion of this session, the participant should be able to: GL, COMP
• Demonstrate the role of genetics, environmental factors, immune cells, and proinflammatory cytokines in the pathogenesis of rheumatoid arthritis.
• Illustrate the clinical features, extra-articular manifestations, and complications of rheumatoid arthritis.
• Utilize and compare various methods of measuring disease activity in rheumatoid arthritis.
• Compare and contrast the mechanisms of action of current and emerging therapies for RA and prescribe treatment for patients with rheumatoid arthritis according to ACR guidelines.